Diabetes, and metabolic diseases in general, are characterized by a complicated interplay between inflammation and metabolic dysregulation, a process that includes multiple inflammatory mediators, and we believe that CD147 sits at the crossroads of this relationship. This evidence concerns the gene BSG and diabetes mellitus.